Chile has become the first country in the Americas and the second globally to be officially verified by the World Health Organization (WHO) for the elimination of leprosy. The achievement recognizes over three decades of sustained public health efforts, including robust surveillance, early detection, effective treatment, continuous follow-up, and comprehensive care for affected individuals. Since the last locally acquired case in 1993, Chile has maintained leprosy as a notifiable condition, ensuring ongoing monitoring and clinical readiness across the health system.
The country’s integrated approach combines primary care for suspected cases with specialized dermatology services, training for clinicians, and holistic support including physiotherapy and rehabilitation, prioritizing early intervention, disability prevention, and social inclusion. Chile’s success has been reinforced by free multidrug therapy provided by the Pan American Health Organization (PAHO), strong legal protections, and policies promoting equitable access to health care for all populations, including migrants and vulnerable groups.
Chile’s verification demonstrates that leprosy elimination is achievable through sustained political commitment, cross-sector collaboration, and adaptive health system planning. Moving forward, the country is encouraged to maintain sensitive surveillance, retain clinical expertise, and ensure ongoing holistic care to sustain elimination, serving as a model for other nations in the Region of the Americas and worldwide.
